Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Innovative-RFK S.p.A. functions as a private equity and venture capital firm, primarily focused on injecting capital into small and medium-sized enterprises (SMEs). The firm supports companies across their developmental spectrum, from initial start-up phases to emerging and established growth. Beyond direct company investments, it also allocates capital to other private equity funds through a fund-of-funds strategy. Its investment preferences span sectors such as biomedical systems, microcredit solutions for SMEs, information technology, the broader high-tech industry, and innovative solutions applicable across various industries. Geographically, Innovative-RFK predominantly targets companies based in Italy. The firm typically commits up to €3 million (approximately $3.54 million) to companies that demonstrate an enterprise value and sales revenue of up to €50 million (around $58.96 million), with an EBITDA reaching up to €5 million (roughly $5.90 million). These investments are funded directly from its own proprietary capital. Innovative-RFK is flexible in its ownership approach, acquiring either minority or majority equity stakes in its portfolio companies. An Initial Public Offering (IPO) serves as its preferred exit strategy, typically targeted within an ambitious 18 to 24-month timeframe. Innovative-RFK S.p.A. was established in 2017 and is headquartered in Milan, Italy.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB